Published in PLoS One on March 22, 2013
A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet (2016) 3.16
Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev (2014) 1.03
Toward a unified biosignature for tuberculosis. Cold Spring Harb Perspect Med (2014) 0.99
The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev (2015) 0.92
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88
Comparison of the tuberculin skin test and interferon gamma release assay for the screening of tuberculosis in adolescents in close contact with tuberculosis TB patients. PLoS One (2014) 0.86
Association between South African high-school learners' knowledge about tuberculosis and their intention to seek healthcare. Glob Health Action (2013) 0.85
Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children. Pediatr Infect Dis J (2015) 0.78
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans. PLoS Pathog (2016) 0.78
Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study. BMC Med (2016) 0.77
Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009-2010; a retrospective cross-sectional study. BMC Public Health (2015) 0.76
A review of clinical models for the evaluation of human TB vaccines. Hum Vaccin Immunother (2016) 0.75
Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines. PLoS One (2017) 0.75
Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol. BMJ Open (2017) 0.75
Incidence of tuberculosis among school-going adolescents in South India. BMC Public Health (2016) 0.75
Engaging adolescents in tuberculosis and clinical trial research through drama. Trials (2016) 0.75
Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination. Int J Tuberc Lung Dis (2017) 0.75
BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J (1977) 4.48
Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis (2006) 2.99
Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet (2005) 2.38
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med (2012) 2.32
Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis (Edinb) (2012) 2.27
Cell mediated immunity in children with scar-failure following BCG vaccination. Indian Pediatr (1998) 1.70
The social epidemiology of tuberculosis in South Africa: a multilevel analysis. Soc Sci Med (2007) 1.70
Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis (1996) 1.70
Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status. PLoS One (2011) 1.63
Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study. BMC Infect Dis (2011) 1.62
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
Consensus statement on diagnostic end points for infant tuberculosis vaccine trials. Clin Infect Dis (2011) 1.25
Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis (2011) 1.20
BCG vaccination: 90 years on and still so much to learn ... Thorax (2010) 1.00
The clinical and radiological features of tuberculosis in adolescents. Ann Trop Paediatr (2000) 0.93
Active tuberculosis among adolescents in toronto, Canada: clinical features and delays in diagnosis. Pediatr Infect Dis J (2007) 0.89
Clinical trials of TB vaccines: harmonization and cooperation. Tuberculosis (Edinb) (2012) 0.89
Perspectives in adolescent tuberculosis: three decades of experience. Pediatrics (1986) 0.89
Tuberculosis in adolescents: A French retrospective study of 52 cases. Pediatr Infect Dis J (2006) 0.85
Tuberculin skin test reactions by time of reading among Dutch travellers. Int J Tuberc Lung Dis (2003) 0.85
Key issues in the clinical development and implementation of TB vaccines in South Africa. Tuberculosis (Edinb) (2012) 0.80
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (2013) 8.18
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis (2012) 4.60
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am J Respir Crit Care Med (2010) 2.64
The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J (2011) 2.47
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med (2014) 2.42
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med (2012) 2.32
Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis (2008) 2.29
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol (2010) 2.25
Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis (2011) 2.24
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial. BMJ (2008) 2.17
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis (2008) 2.05
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med (2010) 2.03
Tuberculosis outbreaks predicted by characteristics of first patients in a DNA fingerprint cluster. Am J Respir Crit Care Med (2008) 1.78
The social epidemiology of tuberculosis in South Africa: a multilevel analysis. Soc Sci Med (2007) 1.70
High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa. Emerg Infect Dis (2007) 1.65
Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med (2011) 1.65
Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South Africa. Bull World Health Organ (2009) 1.62
Pediatric intensive care in South Africa: an account of making optimum use of limited resources at the Red Cross War Memorial Children's Hospital*. Pediatr Crit Care Med (2014) 1.48
No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health (2009) 1.47
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. Tuberculosis (Edinb) (2013) 1.34
Implementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda. BMC Infect Dis (2013) 1.33
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults. Am J Respir Crit Care Med (2013) 1.31
Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting. BMC Med Ethics (2008) 1.27
Consensus statement on diagnostic end points for infant tuberculosis vaccine trials. Clin Infect Dis (2011) 1.25
Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics (2009) 1.23
Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa. J Infect Dis (2011) 1.17
HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis (2009) 1.12
Childhood tuberculosis: old and new vaccines. Paediatr Respir Rev (2007) 1.10
High incidence of pulmonary tuberculosis persists a decade after immigration, The Netherlands. Emerg Infect Dis (2004) 1.09
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am J Respir Crit Care Med (2012) 1.09
The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents. Am J Respir Crit Care Med (2015) 1.08
Prevalence of cutaneous adverse effects of hairdressing: a systematic review. Arch Dermatol (2006) 1.02
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J (2006) 0.99
Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands. BMC Public Health (2009) 0.99
The acceptability of rat trap use over pesticides for rodent control in two poor urban communities in South Africa. Environ Health (2012) 0.99
Experience of violence and socioeconomic position in South Africa: a national study. PLoS One (2007) 0.99
Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine. Antimicrob Agents Chemother (2012) 0.99
Clinical audit of diabetes management can improve the quality of care in a resource-limited primary care setting. Int J Qual Health Care (2012) 0.96
Association between passive smoking and infection with Mycobacterium tuberculosis in children. Pediatrics (2007) 0.94
New vaccines against tuberculosis. Clin Chest Med (2009) 0.93
Utilization of HIV and tuberculosis services by health care workers in Uganda: implications for occupational health policies and implementation. PLoS One (2012) 0.92
Time to symptom resolution in young children treated for pulmonary tuberculosis. Pediatr Infect Dis J (2014) 0.92
Distribution of brain infarction in children with tuberculous meningitis and correlation with outcome score at 6 months. Pediatr Radiol (2006) 0.91
Tuberculosis treatment outcome monitoring in European Union countries: systematic review. Eur Respir J (2012) 0.91
How participatory is parental consent in low literacy rural settings in low income countries? Lessons learned from a community based study of infants in South India. BMC Med Ethics (2011) 0.91
Educational outreach to general practitioners reduces children's asthma symptoms: a cluster randomised controlled trial. Implement Sci (2007) 0.90
Analysing the socioeconomic determinants of hypertension in South Africa: a structural equation modelling approach. BMC Public Health (2014) 0.90
Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis. PLoS One (2006) 0.89
Determinants of marginal traction alopecia in African girls and women. J Am Acad Dermatol (2008) 0.89
Hospital-acquired hyponatremia is associated with excessive administration of intravenous maintenance fluid. Pediatrics (2004) 0.88
Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. J Paediatr Child Health (2007) 0.88
Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol (2008) 0.87
Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trials. Vaccine (2011) 0.87
Burden of tuberculosis disease among adolescents in a rural cohort in Eastern Uganda. BMC Infect Dis (2013) 0.87
Cataract and glaucoma case detection for Vision 2020 programs in Africa: an evaluation of 6 possible screening tests. J Glaucoma (2009) 0.86
Adolescent experiences in a vaccine trial: a pilot study. S Afr Med J (2011) 0.86
Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics. Clin Infect Dis (2011) 0.85
High yield of culture-based diagnosis in a TB-endemic setting. BMC Infect Dis (2012) 0.85
An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda. Tuberc Res Treat (2012) 0.85
Knowledge and acceptability of patient-specific infection control measures for pulmonary tuberculosis. Am J Infect Control (2013) 0.84
Developing vaccinology expertise for Africa: six years and counting. Vaccine (2011) 0.84
Screening for TB in high school adolescents in a high burden setting in South Africa. Tuberculosis (Edinb) (2013) 0.83